Predictors of reduced relative dose intensity and its relationship to mortality in women receiving multi-agent chemotherapy for epithelial ovarian cancer-Reference-Cited by-同舟云学术

Predictors of reduced relative dose intensity and its relationship to mortality in women receiving multi-agent chemotherapy for epithelial ovarian cancer

Published:2013-04 Issue:1 Volume:129 Page:74-80
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Hanna Rabbie K.,Poniewierski Marek S.,Laskey Robin A.,Lopez Micael A.,Shafer Aaron,Van Le Linda,Crawford Jeffrey,Dale David C.,Gehrig Paola A.,Secord Angeles Alvarez,Havrilesky Laura J.,Lyman Gary H.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference35 articles.

1. The importance of dose intensity in chemotherapy of metastatic breast cancer;Hryniuk;J Clin Oncol,1984

2. Relative dose intensity of chemotherapy and its impact on outcomes in patients with early breast cancer or aggressive lymphoma;Wildiers;Crit Rev Oncol Hematol,2011

3. High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest;Conte;J Clin Oncol,1996

4. Lack of impact of platinum dose intensity on the outcome of ovarian cancer patients. 10-year results of a prospective randomised phase III study comparing carboplatin–cisplatin with cyclophosphamide–cisplatin;Dittrich;Eur J Cancer,2003

5. Randomized trial of dose-intensity with single-agent carboplatin in patients with epithelial ovarian cancer. London Gynaecological Oncology Group;Gore;J Clin Oncol,1998

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are exercise and sitting time during chemotherapy for ovarian cancer associated with treatment-related side-effects, chemotherapy completion and survival?;Gynecologic Oncology;2024-11

2. Effects of a combined exercise and dietary intervention on clinical outcomes in patients with ovarian cancer: the Physical Activity and Dietary intervention in OVArian cancer (PADOVA) randomized controlled trial;International Journal of Gynecologic Cancer;2024-09-07

3. Romiplostim in chemotherapy‐induced thrombocytopenia: A review of the literature;Cancer Medicine;2024-08

4. Effectiveness and safety of empegfilgrastim (Extimia®) in patients with solid tumors receiving cytotoxic therapy: final results of the DEFENDOR study;Journal of Modern Oncology;2024-07-03

5. Olaparib maintenance therapy for platinum‐sensitive relapsed ovarian cancer at a single institution: A retrospective study;Journal of Obstetrics and Gynaecology Research;2024-05-14